AR023873A1 - Formulacion - Google Patents
FormulacionInfo
- Publication number
- AR023873A1 AR023873A1 ARP000102193A ARP000102193A AR023873A1 AR 023873 A1 AR023873 A1 AR 023873A1 AR P000102193 A ARP000102193 A AR P000102193A AR P000102193 A ARP000102193 A AR P000102193A AR 023873 A1 AR023873 A1 AR 023873A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulation
- edisilate
- clomethiazole
- methylthiazole
- edisylate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Formulacion parenteral de edisilato de 5-(2-cloroetil)-4-metiltiazol (genéricamente conocido como edisilato de clometiazol) que tiene propiedadesantimicrobianas mejoradas además de estabilidad física, química y microbiologica como así también compatibilidad biologica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901658A SE9901658D0 (sv) | 1999-05-06 | 1999-05-06 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023873A1 true AR023873A1 (es) | 2002-09-04 |
Family
ID=20415507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102193A AR023873A1 (es) | 1999-05-06 | 2000-05-05 | Formulacion |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1178798A1 (es) |
JP (1) | JP2002544164A (es) |
AR (1) | AR023873A1 (es) |
AU (1) | AU4792200A (es) |
SE (1) | SE9901658D0 (es) |
TN (1) | TNSN00094A1 (es) |
WO (1) | WO2000067753A1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK733888A (da) * | 1988-01-12 | 1989-07-13 | Fujisawa Pharmaceutical Co | Stabiliseringsmiddel |
IL91856A0 (en) * | 1988-10-11 | 1990-06-10 | Schiapparelli Salute Spa | Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
SE8900564D0 (sv) * | 1989-02-17 | 1989-02-17 | Astra Ab | Novel medicinal use |
SE9002659D0 (sv) * | 1990-08-15 | 1990-08-15 | Astra Ab | New pharmaceutical formulations |
-
1999
- 1999-05-06 SE SE9901658A patent/SE9901658D0/xx unknown
-
2000
- 2000-05-03 TN TNTNSN00094A patent/TNSN00094A1/fr unknown
- 2000-05-04 EP EP00930026A patent/EP1178798A1/en not_active Withdrawn
- 2000-05-04 JP JP2000616779A patent/JP2002544164A/ja active Pending
- 2000-05-04 WO PCT/SE2000/000876 patent/WO2000067753A1/en not_active Application Discontinuation
- 2000-05-04 AU AU47922/00A patent/AU4792200A/en not_active Abandoned
- 2000-05-05 AR ARP000102193A patent/AR023873A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002544164A (ja) | 2002-12-24 |
SE9901658D0 (sv) | 1999-05-06 |
EP1178798A1 (en) | 2002-02-13 |
WO2000067753A1 (en) | 2000-11-16 |
TNSN00094A1 (fr) | 2002-05-30 |
AU4792200A (en) | 2000-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37994A (es) | Moléculas de adn correspondientes a evento transgénico mon88017 y métodos para su detección | |
HRP20070012A2 (en) | Immunostimulatory oligonucleotide multimers | |
ATE330038T1 (de) | Nukleinsäure-biosensor | |
AR052980A1 (es) | Preparacion de dispersiones polimericas de etileno - acido acrilico neutralizadas y uso en medios de impresion para mejorar la adhesion de pigmento organico digital | |
ATE548391T1 (de) | Gefangene bindungsproteine als biosensoren | |
CR8385A (es) | Pirimidinas sustituidas con sulfoximina como inhibidores de cdk y/o vegf, su preparacion y sus usos como medicamento | |
CN103667141B (zh) | 一种工业污水处理菌剂 | |
ECSP056111A (es) | Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica | |
WO2005040317A3 (en) | Fuel substance and associated cartridge for fuel cell | |
WO2008092041A3 (en) | Optical biosensors | |
WO2005067498A3 (en) | Bioreactor systems and disposable bioreactor | |
WO2009034927A1 (ja) | 細胞培養器具及びこれを用いた細胞培養方法 | |
MXPA03005548A (es) | Metodos para la produccion de proteinas multimericas, y composiciones relacionadas. | |
DE502005002929D1 (de) | Orale darreichungsform enthaltend probiotische bakterien | |
WO2004098634A3 (en) | Protein arginine n-methyltransferase 2 (prmt-2) | |
BR0114199A (pt) | Sequências de nucleotìdeos que medeiam a fertilidade masculina e métodos de uso das mesmas | |
ATE549041T1 (de) | Bakterienbindendes wischtuch | |
BRPI0416710A (pt) | composição e método para inibir o crescimento de microorganismos em fibras não-celulósicas, fibras não-celulósicas e uso da composição para inibir o crescimento de microorganismos em fibras não-celulósicas | |
CL2004000979A1 (es) | Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida. | |
AR058185A1 (es) | Reactivo para sensores de prueba que contiene polimeros de celulosa | |
RS51896B (en) | The use of glucose isomerase in the treatment of fructose intolerance | |
BRPI0409326A (pt) | método para identificação e obtenção de ácidos nucléicos capazes de modificar a toleráncia ao estresse em plantas | |
UY29163A1 (es) | Derivados de piridina, su preparación y su aplicación en terapéutica | |
AR023873A1 (es) | Formulacion | |
AR046843A1 (es) | Carboxamidas sililadas |